TDOC · XBRL financial data
Teladoc Health financial statements, every quarter
The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (TDOC's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 661* | 646 | 642 | 641 | 640* | 629 | 632 | 626 | 642* | 614 | 607 | 605 |
| Research and development | 90* | 81 | 77 | 72 | 77* | 70 | 69 | 68 | 72* | 68 | 63 | 66 |
| General and administrative | 109* | 112 | 110 | 114 | 100* | 113 | 108 | 103 | 108* | 102 | 104 | 107 |
| Operating income (loss) | (35)* | (87) | (841) | (44) | (48)* | (121) | (54) | (52) | (36)* | (62) | (37) | (28) |
| Interest income | 14* | 14 | 14 | 15 | 14* | 13 | 10 | 7 | 7* | 6 | 6 | 7 |
| Interest expense | 6* | 6 | 6 | 6 | 7* | 6 | 4 | 5 | 5* | 5 | 5 | 5 |
| Other income (expense) | 2* | (0) | (1) | 2 | (7)* | 2 | 8 | (1) | 0* | (0) | (2) | (0) |
| Income tax expense (benefit) | 4* | 3 | 4 | 1 | 0* | (18) | (8) | (1) | (8)* | 3 | 1 | 1 |
| Net income (loss) | (29)* | (82) | (838) | (33) | (48)* | (93) | (33) | (50) | (25)* | (64) | (39) | (27) |
| Earnings per share, basic USD per share | (0.17)* | (0.49) | (4.92) | (0.19) | (0.28)* | (0.53) | (0.19) | (0.28) | (0.14)* | (0.36) | (0.21) | (0.15) |
| Earnings per share, diluted USD per share | (0.17)* | (0.49) | (4.92) | (0.19) | (0.28)* | (0.53) | (0.19) | (0.28) | (0.14)* | (0.36) | (0.21) | (0.15) |
| Weighted average shares, basic millions of shares | 166* | 168 | 170 | 171 | 173* | 174 | 176 | 177 | 178* | 179 | 181 | 182 |
| Weighted average shares, diluted millions of shares | 166* | 168 | 170 | 171 | 173* | 174 | 176 | 177 | 178* | 179 | 181 | 182 |
Balance sheet
CSVFiscal quarters (TDOC's year ends in late December)
Cash flows
CSVFiscal quarters (TDOC's year ends in late December)
| In millions of dollars | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 | Sep 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (29)* | (82) | (838) | (33) | (48)* | (93) | (33) | (50) | (25)* | (64) | (39) | (27) |
| Stock-based compensation | 47* | 42 | 42* | 34* | 27* | 25 | 22* | 17* | 16* | 15 | 9* | 12* |
| Net cash from operating activities | 130* | 9 | 89* | 110* | 86* | 16 | 91* | 99* | 88* | 10 | 65* | 106* |
| Purchases of property and equipment | 1* | 1 | 2* | 2* | 6* | 3 | 1* | 2* | 3* | 2 | 1* | 1* |
| Net cash from investing activities | (37)* | (36) | (28)* | (31)* | (30)* | (123) | (60)* | (49)* | (34)* | (37) | (42)* | (31)* |
| Net cash from financing activities | (2)* | 2 | 4* | 1* | 2* | 1 | (550)* | (4)* | 1* | (2) | 1* | 0* |
Compare with peers
SIC 8011 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (8011) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
- A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Teladoc Health | 850 | 605 | 106* | 182.3M | — | 10-QSep 30, 2026 |
| LifeMD | 25 | 47 | (6.9)* | 48.2M | 3.6 quarters | 10-QJun 30, 2026 |
| Hims & Hers Healthadded: same SIC | 610 | 753 | (36)* | not reported | — | 10-QJun 30, 2026 |
| Starling Oncologyadded: same SIC | 41 | 161 | 12* | 101.9M | — | 10-QJun 30, 2026 |
| Airsculpt Technologiesadded: same SIC | 19 | 43 | (1.2)* | 72.1M | 15.2 quarters | 10-QJun 30, 2026 |
| SBC Medical Group Holdingsadded: same SIC | 184 | 49 | 23* | 102.8M | — | 10-QJun 30, 2026 |
| Cardiff Lexingtonadded: same SIC | 0.2 | 2.2 | (0.7)* | 15.6M | 0.3 quarters | 10-QJun 30, 2026 |
| HealthLynkedadded: same SIC | 0 | not reported | (0.4)* | 3.0M | 0.0 quarters | 10-QJun 30, 2026 |
| Aunaadded: same SIC | 236 | year only | year only | not reported | — | 20-F/ADec 31, 2024 |
Not investment advice. Not affiliated with the U.S. SEC.